Physician profile
Alfredo Iardino
NPI 1558712828
$25,887.39
in general payments reported to CMS, 2019-2025
14 companies · $9,550 in 2025
The $9,550 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $664 · 2023: $14K · 2024: $2,049 · 2025: $9,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Consulting Fee: $6,000 · Travel and Lodging: $4,323 · Food and Beverage: $2,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Consulting Fee | $6,000.00 |
| Travel and Lodging | $4,322.62 |
| Food and Beverage | $2,901.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,223.44 | 2023-2025 | Da Vinci Surgical System, Ion |
| Pulmonx Corporation | $10,633.64 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Cook Incorporated | $455.21 | 2022 | |
| Baxter Healthcare | $354.39 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| United Therapeutics Corporation | $263.97 | 2024-2025 | Tyvaso, Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.39 | 2022-2025 | Ofev, Stiolto Respimat, Jardiance |
| Livanova USA, INC. | $251.28 | 2023 | Lifesparc |
| Cook Medical LLC | $181.53 | 2022 | |
| Glaxosmithkline, LLC. | $84.07 | 2022-2025 | Nucala |
| Astrazeneca Pharmaceuticals Lp | $79.47 | 2024 | Airsupra, Fasenra |
| Abiomed | $43.20 | 2023 | Impella |
| Philips North America LLC | $26.54 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.15 | 2023 | Lifevest |
| Verona Pharma, INC. | $18.11 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfredo Iardino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.